Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelomonocytic, Chronic

Explore clinical trials studying Leukemia, Myelomonocytic, Chronic. Study availability and eligibility vary by location and protocol.

419 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelomonocytic, Chronic trial results

Completed

Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine

NCT03588078

Conditions
Acute Myeloid Leukemia With Gene Mutations, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Bruno Quesnel Lille, France
  • Dr Pierre Peterlin and Pr Patrice Chevalier Nantes, France
  • Hôpital Archet 1 Nice, France
  • Hôpital Saint Louis - Hématologie Séniors Paris, France
View Trial Details
Completed

A Study of E7820 in People With Bone Marrow (Myeloid) Cancers

NCT05024994

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • University of Miami (Data Collection AND Specimen Analysis Only) Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Completed

NTX-301 in MDS/AML

NCT04167917

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

NCT05665530

Conditions
Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Bone Marrow Diseases, +41 more
Locations
  • City of Hope Duarte, California, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
View all 24 locations
View Trial Details
Completed

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

NCT01139970

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +45 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details

Related conditions